DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Neuro-Oncology · 05.08.2024 · 26 (8) · 1367-1387
DOI: 10.1093/neuonc/noae072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 22.03.2024. Verfasst von Rifaquat Rahman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, DNA Damage. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
DNA damage response (DDR) mechanisms are critical to maintenance of overall genomic stability, and their dysfunction can contribute to oncogenesis. Significant advances in our understanding of DDR pathways have raised the possibility of developing therapies that exploit these processes. In this expert-driven consensus review, we examine mechanisms of response to DNA damage, progress in development of DDR inhibitors in IDH-wild-type glioblastoma and IDH-mutant gliomas, and other important considerations such as biomarker development, preclinical models, combination therapies, mechanisms of resistance and clinical trial design considerations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.
- Division of Cancer Sciences, University of Manchester, Manchester, UK.
- Division of Neuro-Oncology, University of California San Francisco, San Francisco, California, USA.
- Department of Radiation Oncology, New York University, New York, New York, USA.
- National Brain Tumor Society, Newton, Massachusetts, USA.
ORCID-Profile: Patrick Y Wen
Förderung
- NCI NIH HHS
Zitieren
APA
Rahman, R., Shi, D. D., Reitman, Z. J., Hamerlik, P., de Groot, J. F., Haas-Kogan, D. A., D'Andrea, A. D., Sulman, E. P., Tanner, K., Agar, N. Y. R., Sarkaria, J. N., Tinkle, C. L., Bindra, R. S., Mehta, M. P., & Wen, P. Y. (2024). DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology. Neuro-Oncology, 26(8), 1367-1387. https://doi.org/10.1093/neuonc/noae072
Vancouver
Rahman R, Shi DD, Reitman ZJ, Hamerlik P, de Groot JF, Haas-Kogan DA, et al. DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology. Neuro-Oncology. 2024;26(8):1367-1387. doi:10.1093/neuonc/noae072
BibTeX
@article{Rahman2024,
author = {Rahman, Rifaquat and Shi, Diana D and Reitman, Zachary J and Hamerlik, Petra and de Groot, John F and Haas-Kogan, Daphne A and D'Andrea, Alan D and Sulman, Erik P and Tanner, Kirk and Agar, Nathalie Y R and Sarkaria, Jann N and Tinkle, Christopher L and Bindra, Ranjit S and Mehta, Minesh P and Wen, Patrick Y},
title = {DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology},
journal = {Neuro-Oncology},
year = {2024},
volume = {26},
number = {8},
pages = {1367--1387},
doi = {10.1093/neuonc/noae072}
}
EUVIMED